Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC

International Journal of Cancer

Volumn 132, Issue 9, 2013, Pages 1986-1995

  Oliemuller, Erik ^a   Peláez, Rafael ^a   Garasa, Saray ^a   Pajares, María J ^a   Agorreta, Jackeline ^a   Pío, Rubén ^a,b   Montuenga, Luis M ^a,b   Teijeira, Alvaro ^a   Llanos, Susana ^c   Rouzaut, Ana ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

CRMP 2; mitosis; NSCLC; prognostic

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; TUBULIN;

ARTICLE; CANCER CELL; CANCER PROGNOSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE MARKER; DRUG TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MITOSIS SPINDLE; NUCLEAR SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ADENOCARCINOMA; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MICROTUBULES; MIDDLE AGED; MITOTIC SPINDLE APPARATUS; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEOPLASM STAGING; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROGNOSIS; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84874111238     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27881     Document Type: Article

References (38)

1. Hubert T, Van Impe K, Vandekerckhove J, et al. The actin-capping protein CapG localizes to microtubule-dependent organelles during the cell cycle. Biochem Biophys Res Commun 2009; 380: 166-70.
2. Rovini A, Savry A, Braguer D, et al. Microtubule-targeted agents: when mitochondria become essential to chemotherapy. Biochim Biophys Acta 2011; 1807: 679-88.
3. Downing KH, Nogales E,. Tubulin and microtubule structure. Curr Opin Cell Biol 1998; 10: 16-22.
4. Bhat KMR, Setaluri V,. Microtubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res 2007; 13: 2849-54.
5. Lin P, Chan P, Hall C, et al. Collapsin response mediator proteins (CRMPs) are a new class of microtubule-associated protein (MAP) that selectively interacts with assembled microtubules via a taxol-sensitive binding interaction. J Biol Chem 2011; 286: 41466-78.
6. Schmidt E, Strittmatter S,. The CRMP family of proteins and their role in Sema3A signaling. Adv Exp Med Biol 2007; 600: 1-11.
7. Hamajima N, Matsuda K, Sakata S, et al. A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. Gene 1996; 180: 157-63.
8. Fukata Y, Itoh T, Kimura T, et al. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat Cell Biol 2002; 4: 583-91.
9. Arimura N, Hattori A, Kimura T, et al. CRMP-2 directly binds to cytoplasmic dynein and interferes with its activity. J Neurochem 2009; 111: 380-90.
10. Nishimura T, Fukata Y, Kato K, et al. CRMP-2 regulates polarized numb-mediated endocytosis for axon growth. Nat Cell Biol 2003; 5: 819-26.
11. Kawano Y, Yoshimura T, Tsuboi D, et al. CRMP-2 is involved in kinesin-1-dependent transport of the sra-1/WAVE1 complex and axon formation. Mol Cell Biol 2005; 25: 9920-35.
12. Arimura N, Mnager C, Kawano Y, et al. Phosphorylation by rho kinase regulates CRMP-2 activity in growth cones. Mol Cell Biol 2005; 25: 9973-84.
13. Varrin-Doyer M, Vincent P, Cavagna S, et al. Phosphorylation of collapsin response mediator protein 2 on tyr-479 regulates CXCL12-induced T lymphocyte migration. J Biol Chem 2009; 284: 13265-76.
14. Tahimic CG, Tomimatsu N, Nishigaki R, et al. Evidence for a role of collapsin response mediator protein-2 in signaling pathways that regulate the proliferation of non-neuronal cells. Biochem Biophys Res Commun 2006; 340: 1244-50.
15. Gu Y, Ihara Y,. Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules. J Biol Chem 2000; 275: 17917-20.
16. Sampath D, Plunkett W,. Design of new anticancer therapies targeting cell cycle checkpoint pathways. Curr Opin Oncol 2001; 13: 484-90.
17. Travis WD, Brambilla E, Müller-Hermelink HK, et al. World health organization classification of tumours. pathology and genetics of tumours of the lung, pleura, thymus and heart, 3rd edn. Lyon, France: IARC Press, 2004. 8 p.
18. Mountain CF,. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-7.
19. Irigoyen M, Pajares MJ, Agorreta J, et al. TGFBI expression is associated with a better response to chemotherapy in NSCLC. Mol Cancer 2010; 9: 130.
20. McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 2005; 93: 387-91.
21. Llanos S, Efeyan A, Monsech J, et al. A high-throughput loss-of-function screening identifies novel p53 regulators. Cell Cycle 2006; 5: 1880-5.
22. Irigoyen M, Anso E, Martinez E, et al. Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta 2007; 1773: 880-90.
23. Hafner C,. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci USA 2010; 107: 20780-5.
24. Decordier I, Cundari E, Kirsch Volders M,. Survival of aneuploid, micronucleated and/or polyploid cells: crosstalk between ploidy control and apoptosis. Mutat Res 2008; 651: 30-9.
25. McErlean A, Ginsberg M,. Epidemiology of lung cancer. Semin Roentgenol 2011; 46: 173-7.
26. Perez E,. Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Therap 2009; 8: 2086-95.
27. Hanahan D, Weinberg R,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
28. Ito T, Kagoshima M, Sasaki Y, et al. Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung. Mech Dev 2000; 97: 35-45.
29. Pan S, Chao Y, Chen H, et al. Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients. Lung Cancer 2010; 67: 93-100.
30. Meyronet D, Massoma P, Thivolet F, et al. Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma. Am J Surg Pathol 2008; 32: 1699-708.
31. Piehl M, Tulu US, Wadsworth P, et al. Centrosome maturation: Measurement of microtubule nucleation throughout the cell cycle by using GFP-tagged EB1. Proc Natl Acad Sci USA 2004; 101: 1584-8.
32. Kline-Smith S, Walczak C,. Mitotic spindle assembly and chromosome segregation: refocusing on microtubule dynamics. Mol Cell 2004; 15: 317-27.
33. McIntosh JR, Grishchuk E, West R,. Chromosome-microtubule interactions during mitosis. Annu Rev Cell Dev Biol 2002; 18: 193-219.
34. Glotzer M,. The molecular requirements for cytokinesis. Science 2005; 307: 1735-9.
35. Schiel J, Park K, Morphew M, et al. Endocytic membrane fusion and buckling-induced microtubule severing mediate cell abscission. J Cell Sci 2011; 124: 1411-24.
36. Uehara R, Goshima G,. Functional central spindle assembly requires de novo microtubule generation in the interchromosomal region during anaphase. J Cell Biol 2010; 191: 259-67.
37. Maresca T, Salmon ED,. Welcome to a new kind of tension: translating kinetochore mechanics into a wait-anaphase signal. J Cell Sci 2010; 123: 825-35.
38. Montagnac G, Echard A, Chavrier P,. Endocytic traffic in animal cell cytokinesis. Curr Opin Cell Biol 2008; 20: 454-61.